CME Group(US:CME)2026-02-04 14:32Financial Data and Key Metrics Changes - CME Group achieved record revenues of $6.5 billion in 2025, a 6% increase compared to 2024, with annual revenue records in five out of six asset classes [11] - Adjusted net income reached $4.1 billion, resulting in a 9% growth in adjusted earnings per share for the year [11] - In Q4 2025, revenue was $1.65 billion, an 8% increase from Q4 2024, with an adjusted operating margin of 67% [12] Business Line Data and Key Metrics Changes - Average daily volume increased by 6% to 2,128.1 million contracts, with record volumes in interest rate, energy, metals, agricultural, and crypto complexes [5] - Market data revenue surpassed $800 million for the first time, up 13% from 2024 [11] - Micro products saw a 59% increase in Q4 to a record 4.4 million contracts per day [8] Market Data and Key Metrics Changes - International business averaged 8.4 million contracts per day, up 8% from the previous record set in 2024 [5] - Average daily margin savings for customers reached $80 billion, an increase of approximately $20 billion over the past year [6] Company Strategy and Development Direction - CME Group is focused on innovation, launching Event Contracts to expand its customer base and provide greater access to markets [8] - The company plans to introduce 24/7 trading for its entire crypto suite and is evaluating whether other asset classes would benefit from 24/7 trading [10] - CME Securities Clearing is set to launch later this year, enhancing capital efficiencies for the industry [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the health of the customer base, noting that open positions are around 125 million and that retail and institutional segments are growing [18][19] - The macro landscape is complex, but CME Group remains focused on providing premier risk management tools [10] - The company is encouraged by strong activity in early 2026, continuing the momentum from a record-setting year [15] Other Important Information - CME Group repurchased $256 million in shares during Q4 and an additional $276 million in 2026 [12] - The board approved the use of OSTTRA proceeds for share repurchases over time [12] - The company expects total adjusted operating expenses to be approximately $1.695 billion in 2026 [14] Q&A Session Summary Question: Health of customer base amid volatility - Management indicated that the customer base is healthy, with open positions and volume increases across all regions, despite raised margin requirements in the metals complex [18][19] Question: Engagement in prediction markets - Management noted strong interest from new individual participants and institutional market makers in prediction markets, indicating a robust pipeline for future engagement [25][26] Question: Pricing changes and market data - Management discussed a 3.5% rack rate increase for market data products and emphasized the importance of subscription revenue growth [35][37] Question: Cross-margining programs and treasury clearing - Management confirmed operational readiness for the CME FICC cross-margining program and discussed the anticipated benefits of treasury clearing for collateral balances [89][94] Question: Tokenized collateral and AI disintermediation risk - Management is exploring tokenized cash initiatives and believes AI will enhance rather than disrupt their data business [82][68]